Fred P.  Lampropoulos net worth and biography

Fred Lampropoulos Biography and Net Worth

Fred Lampropoulos has been in the medical device industry for more than 30 years. After serving as the Chairman and Chief Executive of Utah Medical, Lampropoulos founded Merit Medical Systems, Inc., in 1987, where he currently serves as Chairman and Chief Executive Officer (CEO).

Lampropoulos has invented and holds more than 200 patents on devices used in the diagnostic and therapeutic treatment of cardiac, peripheral, gastrointestinal, and pulmonary conditions.

He is also highly involved in his community and serves on many boards. Lampropoulos is the recipient of numerous awards, including the Governor’s Medal for Science and Technology and CEO of the Year. He was inducted into the Utah Business Hall of Fame.

Lampropoulos is a former Special Forces Officer and an Honorary Colonel in the Utah National Guard. He holds several honorary doctorates, including Doctorate in Business Administration from Westminster College in Salt Lake City, recognizing his contribution to and development of industry and education within the state of Utah.

What is Fred P. Lampropoulos' net worth?

The estimated net worth of Fred P. Lampropoulos is at least $69.41 million as of March 14th, 2023. Mr. Lampropoulos owns 967,916 shares of Merit Medical Systems stock worth more than $69,409,256 as of April 18th. This net worth approximation does not reflect any other assets that Mr. Lampropoulos may own. Additionally, Mr. Lampropoulos receives a salary of $2,800,000.00 as CEO at Merit Medical Systems. Learn More about Fred P. Lampropoulos' net worth.

How old is Fred P. Lampropoulos?

Mr. Lampropoulos is currently 74 years old. There are 5 older executives and no younger executives at Merit Medical Systems. Learn More on Fred P. Lampropoulos' age.

What is Fred P. Lampropoulos' salary?

As the CEO of Merit Medical Systems, Inc., Mr. Lampropoulos earns $2,800,000.00 per year. Learn More on Fred P. Lampropoulos' salary.

How do I contact Fred P. Lampropoulos?

The corporate mailing address for Mr. Lampropoulos and other Merit Medical Systems executives is 1600 WEST MERIT PARK WAY, SOUTH JORDAN UT, 84095. Merit Medical Systems can also be reached via phone at (801) 253-1600 and via email at [email protected]. Learn More on Fred P. Lampropoulos' contact information.

Has Fred P. Lampropoulos been buying or selling shares of Merit Medical Systems?

Fred P. Lampropoulos has not been actively trading shares of Merit Medical Systems within the last three months. Most recently, Fred P. Lampropoulos sold 24,977 shares of the business's stock in a transaction on Tuesday, March 14th. The shares were sold at an average price of $68.26, for a transaction totalling $1,704,930.02. Following the completion of the sale, the chief executive officer now directly owns 967,916 shares of the company's stock, valued at $66,069,946.16. Learn More on Fred P. Lampropoulos' trading history.

Who are Merit Medical Systems' active insiders?

Merit Medical Systems' insider roster includes A. Anderson (Director), Jill Anderson (Director), David Floyd (Director), Ronald Frost (COO), Fred Lampropoulos (CEO), Brian Lloyd (Insider), F. Millner (Director), Raul Parra, Jr. (CFO), Neil Peterson (COO), Michel Voigt (Insider), Lynne Ward (Director), and Joseph Wright (Insider). Learn More on Merit Medical Systems' active insiders.

Are insiders buying or selling shares of Merit Medical Systems?

In the last twelve months, insiders at the medical instruments supplier sold shares 6 times. They sold a total of 99,817 shares worth more than $7,434,244.71. The most recent insider tranaction occured on March, 12th when CFO Raul Jr. Parra sold 6,480 shares worth more than $479,196.00. Insiders at Merit Medical Systems own 3.7% of the company. Learn More about insider trades at Merit Medical Systems.

Information on this page was last updated on 3/12/2024.

Fred P. Lampropoulos Insider Trading History at Merit Medical Systems

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/14/2023Sell24,977$68.26$1,704,930.02967,916View SEC Filing Icon  
3/1/2023Sell1,483$70.17$104,062.111,012,069View SEC Filing Icon  
3/12/2021Sell4,947$59.60$294,841.20967,916View SEC Filing Icon  
5/20/2020Sell5,000$44.00$220,000.00967,916View SEC Filing Icon  
9/6/2019Sell150,000$30.72$4,608,000.00929,991View SEC Filing Icon  
8/15/2019Sell40,000$36.86$1,474,400.001,079,991View SEC Filing Icon  
See Full Table

Fred P. Lampropoulos Buying and Selling Activity at Merit Medical Systems

This chart shows Fred P Lampropoulos's buying and selling at Merit Medical Systems by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Merit Medical Systems Company Overview

Merit Medical Systems logo
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.
Read More

Today's Range

Now: $71.42
Low: $71.25
High: $72.06

50 Day Range

MA: $75.41
Low: $71.51
High: $80.48

2 Week Range

Now: $71.42
Low: $62.58
High: $85.62

Volume

38,426 shs

Average Volume

497,092 shs

Market Capitalization

$4.15 billion

P/E Ratio

44.09

Dividend Yield

N/A

Beta

0.89